-
1.MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis 有权
Title translation: 用于治疗与新血管生成相关的疾病和病症的MiRNA公开(公告)号:US20140005251A1
公开(公告)日:2014-01-02
申请号:US13933526
申请日:2013-07-02
Applicant: InteRNA Technologies B.V.
Inventor: Sanne WEIJZEN , Roeland Quirinus Jozef SCHAAPVELD , Meriem BOURAJJAJ , Rick Jan VAN HAASTERT , Arjan Willem GRIFFIOEN , Judith Rosina VAN BEIJNUM , Edwin Pieter Johan Gerard CUPPEN , Eugene BEREZIKOV , Andreas Alphons Franciscus Ludovicus VAN PUIJENBROEK , Willemijn Maria GOMMANS , Negar BABAE , Petronella Innocentia VAN NOORT
IPC: C12N15/113 , C12Q1/68
CPC classification number: C12N15/1135 , A61P35/00 , C12N7/00 , C12N15/113 , C12N2310/141 , C12N2320/10 , C12N2320/11 , C12N2320/30 , C12N2320/31 , C12N2710/10043 , C12N2740/15043 , C12Q1/6883 , C12Q1/6886
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.
Abstract translation: 本发明涉及在与新血管生成相关的疾病和病症中的miRNA分子,其等同物或来源的诊断和治疗用途。
-
2.MIRNA FOR TREATING DISEASES AND CONDITIONS ASSOCIATED WITH NEO-ANGIOGENESIS 审中-公开
Title translation: 用于治疗与新生血管发生相关的疾病和病症的MIRNA公开(公告)号:US20160333353A1
公开(公告)日:2016-11-17
申请号:US15227832
申请日:2016-08-03
Applicant: INTERNA TECHNOLOGIES B.V.
Inventor: Sanne WEIJZEN , Roeland Quirinus Jozef SCHAAPVELD , Meriem BOURAJJAJ , Rick Jan VAN HAASTERT , Arjan Willem GRIFFIOEN , Judith Rosina VAN BIEJNUM , Edwin Pieter Johan Gerard CUPPEN , Eugene BEREZIKOV , Andreas Alphons Franciscus Ludovicus VAN PIUJENBROEK , Willemijn Maria GOMMANS , Negar BABAE , Petronella Innocentia VAN NOORT
IPC: C12N15/113 , C12N7/00 , C12Q1/68
CPC classification number: C12N15/1135 , A61P35/00 , C12N7/00 , C12N15/113 , C12N2310/141 , C12N2320/10 , C12N2320/11 , C12N2320/30 , C12N2320/31 , C12N2710/10043 , C12N2740/15043 , C12Q1/6883 , C12Q1/6886
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.
Abstract translation: 本发明涉及在与新血管生成相关的疾病和病症中的miRNA分子,其等同物或来源的诊断和治疗用途。
-
3.
公开(公告)号:US20160017338A1
公开(公告)日:2016-01-21
申请号:US14849777
申请日:2015-09-10
Applicant: INTERNA TECHNOLOGIES B.V.
Inventor: Roeland Quirinus Jozef SCHAAPVELD , Gerardus Wilhelmus Christiaan Theodoor VERHAEGH , Jacobus Antonius SCHALKEN , Andreas Alphons Franciscus Ludovicus van PUIJENBROEK , Willemijn Maria GOMMANS , Sanne WEIJZEN
IPC: C12N15/113 , A61K45/06 , A61N5/10 , A61K31/713
CPC classification number: C12N15/1138 , A61K31/7088 , A61K31/7105 , A61K31/713 , A61K45/06 , A61N5/10 , C12N15/113 , C12N2310/141 , C12N2320/31 , C12N2330/10
Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition).
-
-